Baird Medical Investment Holdings (BDMD) Short term Debt (2023 - 2025)
Baird Medical Investment Holdings has reported Short term Debt over the past 3 years, most recently at $2.6 million for Q4 2025.
- For Q4 2025, Short term Debt rose 203.89% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, up 203.89%, while the annual FY2025 figure was $2.6 million, 203.89% up from the prior year.
- Short term Debt for Q4 2025 was $2.6 million at Baird Medical Investment Holdings, up from $719685.0 in the prior quarter.
- Over five years, Short term Debt peaked at $2.6 million in Q4 2025 and troughed at -$8433.0 in Q2 2024.
- A 3-year average of $1.0 million and a median of $817485.0 in 2023 define the central range for Short term Debt.
- Biggest five-year swings in Short term Debt: rose 6.15% in 2024 and later surged 8634.15% in 2025.
- Year by year, Short term Debt stood at $817485.0 in 2023, then rose by 6.15% to $867772.0 in 2024, then soared by 203.89% to $2.6 million in 2025.
- Business Quant data shows Short term Debt for BDMD at $2.6 million in Q4 2025, $719685.0 in Q2 2025, and $867772.0 in Q4 2024.